CNS Pharmaceuticals, Inc. (CNSP) has a market capitalization of $1.52M and trades at $2.64. The 52-week range is 2.057-34.8.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-35.75.
The stock has a beta of 0.46, operates in the Healthcare sector.
